3-BROMO-4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-PYRIDINE, 95.0%, 250mg

(2S,3R)-3-(((Benzyloxy)carbonyl)amino)-2-hydroxy-4-phenylbutanoic acid, 95.0%, 1g

2-(((1S,2R,4S)-2-((tert-Butoxycarbonyl)amino)-4-(dimethylcarbamoyl)cyclohexyl)amino)-2-oxoacetic acid (Edoxaban Impurity), 97%, 50mg

7-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 1g

(1-methylcyclopentyl)amine hydrochloride, 95.0%, 5g

5,6-dimethyl-2H-1,2,3-benzotriazole hydrate, 98%, 5g

4,4'-(1H-1,2,4-Triazole-3,5-diyl)dipyridine, 97%, 5g

(1S,3S,5S)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBOXAMIDE HCL, 97.0%, 1g

1H-Thieno[2,3-d]imidazol-2(3H)-one, 95.0%, 1g

(3R)-3-Methylpyrrolidin-3-ol hydrochloride, 95+%, 1g

Methyl orotate, 95.0%, 10g

n,3-Diethyl-3h-[1,2,3]triazolo[4,5-d]pyrimidin-7-amine, 98%, 50mg

Gel de sílice rojo/amarillo, 1-3 mm, con indicador, forma de perla, 1 kg, envase de plástico.